TRUMY

PINK Terumo Corp Unsponsored ADR

Oct 28, 2026 · 6:48 AM ET EOD Market Closed

$15.16 ↑ +0.00 (+0.00%) Trading Up from the previous close of $15.16, $0.64 below the day’s high of $15.80

YTD change: +4.55%
vs 20-day SMA: +3.75%
vs 200-day SMA: +8.48%

Price ranges

Previous day

$14.95 $15.80

open $15.80 close $15.16

-$0.64 (-4.05%)

Today

$14.95 $15.80

$15.16

Past week

$14.65 $15.81

from $14.65 now $15.16

+$0.51 (+3.48%)

Past month

$12.91 $15.81

from $14.52 now $15.16

+$0.64 (+4.41%)

This year

$12.08 $16.81

from $14.50 now $15.16

+$0.66 (+4.55%)

Price & Performance

+2.47 (+19.46%) / 6M

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Neutral

The stock is 40.0% away from all-time highs of $25.27
TRUMY is up 5% since the beginning of the year
TRUMY is down 9% over the past 12 months
TRUMY is up 4% over the past 1 month

TRUMY reads neutral: price sits above both the 20- and 200-day averages, the 12-month move is -10.0%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable Yes

EPS $0.300337

Earnings momentum -513.5% Quarterly EPS growth

Quarterly change -513.5%

Valuation

P/E ratio N/A

Enterprise value $23.2B

Beta 0.56

Balance sheet & scale

Income$1.1M

Revenue$7.7B

Cash$1.9B

Debt$2.4M

Income / Debt 0.44×

Company & Peers

Company profile and competitor comparison

Company profile

ExchangePINK

Sector Manufacturing

Sub Sector Miscellaneous Manufacturing

Market cap $22.4B

Terumo Corp. engages in the manufacture and sale of medical products and equipment. It operates through the following segments: Cardiac and Vascular Company, General Hospital Company, and Blood Management Company. The Cardiac and Vascular Company segment offers services and treatments including cardiac and vascular surgery and interventional therapies performed inside blood vessels. The General Hospital Company segment provides infusion and closed anticancer drug infusion systems, measuring devices system with communication functions, diabetes management, adhesion barrier, and peritoneal dialysis. The Blood Management Company segment offers a combination of apheresis collections, manual and automated whole blood processing, and pathogen reduction. The company was founded by Shibasaburo Kitasato on September 17, 1921 and is headquartered in Tokyo, Japan.

Competitor comparison

Ticker	Company	Price	Change
JNJ.CAT	JOHNSON & JOHNSON CDR CAD HEDGED	$34.25	+0.82%
BDX	Becton, Dickinson and Company	$195.03	-0.69%
DXCM	DexCom, Inc.	$78.56	-0.01%
MDLN	Medline, Inc. Class A	$32.38	-3.89%
WST	West Pharmaceutical Services, Inc.	$398.29	+0.90%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.